Схожі ресурси: 50 Years of Immunization—Steps Forward
- Why vaccines to HIV, HCV and Malaria have so far failed - Challenges to developing vaccines against immunoregulating pathogens
- mLife
- ImmunoMedicine
- Global Health Research and Policy
- Dynamical Models of Biology and Medicine
- Public Health Challenges
- BMC Medicine
- Integrative Multi-Omics in Biomedical Research
- BMC Public Health
- International Journal of One Health
- Journal of the International AIDS Society
- npj Health Systems
- Health Care Science
- BJPsych International
- Jurnal Ilmiah Kesehatan Sandi Husada
- GeoHealth
- Tobacco Prevention and Cessation
- Health Economics, Policy and Law
- Annals of Global Health
- Global Challenges
- Clinovate: Advances in Medicine and Healthcare
- Health Expectations
- Acta Universitatis Danubius: Administratio
- Gazeta Médica
Тема: non-COVID-19 vaccine
- Тема: South Kivu
- Тема: immunization
- Тема: vaccine misinformation
- Тема: vaccine reactogenicity
- Тема: adverse reactions
- Тема: adverse events following immunization
- Тема: vaccine injury compensation program
- Тема: cholera
- Тема: oral cholera vaccine
- Тема: vaccination campaign
- Тема: cost
- Тема: cost-effectiveness
- Тема: integration
- Тема: vaccination
- Тема: service delivery
- Тема: systematic review
- Тема: maternal and child health
- Тема: infant
- Тема: HIV
- Тема: malaria
- Тема: family planning
- Тема: poliomyelitis
- Тема: epidemiology
- Тема: vaccine coverage
- Тема: surveillance
- Тема: polio eradication
- Тема: pertussis
- Тема: vaccines
- Тема: diagnosis
- Тема: vaccine security
- Тема: global OPV stockpile
- Тема: immunization policy
- Тема: inactivated poliovirus vaccine (IPV)
- Тема: oral poliovirus vaccine (OPV)
- Тема: vaccine production and distribution
- Тема: global health security
- Тема: poliovirus containment
- Тема: vaccine
- Тема: microplanning
- Тема: microplan
- Тема: LMIC
- Тема: routine childhood vaccines
- Тема: newcomer
- Тема: immunizations
- Тема: access
- Тема: equity
- Тема: qualitative methods
- Тема: Strategic Advisory Group of Experts (SAGE) on Immunization
- Тема: SAGE
- Тема: World Health Organization advisory group
- Тема: global immunization policy
- Тема: immunization strategy
- Тема: vaccination policy
- Тема: vaccination recommendations
- Тема: vaccine hesitancy
- Тема: cancer
- Тема: pediatric
- Тема: immunocompromised
- Тема: public health
- Тема: influenza
- Тема: COVID-19
- Тема: respiratory syncytial virus
- Тема: outbreaks
- Тема: maternal vaccination
- Тема: vaccination week in the Americas
- Тема: pandemic preparedness and response
- Тема: life-course immunization
- Тема: coverage increase
- Тема: zero-dose
- Тема: LMICs
- Тема: hepatitis E
- Тема: HEV 239
- Тема: shorter schedule
- Тема: immunogenicity
- Тема: efficacy
- Тема: zero dose
- Тема: under-five vaccination
- Тема: human centered design
- Тема: advocacy
- Тема: community-centric intervention
- Тема: National Immunization Technical Advisory Groups
- Тема: NITAGs
- Тема: WHO–UNICEF Joint Reporting Form
- Тема: measles
- Тема: under-immunized
- Тема: vaccine inequity
- Тема: herpes zoster
- Тема: varicella zoster virus
- Тема: health policy
- Тема: Central Africa
- Тема: big catch-up
- Тема: peer learning
- Тема: measles, mumps, and rubella
- Тема: MMR
- Тема: Denmark
- Тема: school
- Тема: healthcare
- Тема: education
- Тема: economic outcomes
- Тема: HPV vaccination
- Тема: girls
- Тема: supplementary immunization activities
- Тема: coverage
- Тема: disparities
- Тема: Togo
- Тема: immunization equity
- Тема: children with disabilities
- Тема: low- and middle-income countries
- Тема: vaccine barriers
- Тема: vaccination strategies
- Тема: inclusive healthcare
- Тема: adult
- Тема: health workers
- Тема: pregnant women
- Тема: elderly
- Тема: chronic diseases
- Тема: Shigella
- Тема: children
- Тема: phase III study
- Тема: endpoints
- Тема: safety
- Тема: dengue
- Тема: Qdenga
- Тема: CYD-TDV
- Тема: TAK-003
- Тема: Wolbachia
- Тема: antibody-dependent enhancement
- Тема: mRNA vaccines
- Тема: school-based programs
- Тема: n/a
- Тема: thema EDItEUR::M Medicine and Nursing
Тема: Vibrio cholerae
- Тема: South Kivu
- Тема: immunization
- Тема: vaccine misinformation
- Тема: vaccine reactogenicity
- Тема: adverse reactions
- Тема: adverse events following immunization
- Тема: vaccine injury compensation program
- Тема: cholera
- Тема: oral cholera vaccine
- Тема: vaccination campaign
- Тема: cost
- Тема: cost-effectiveness
- Тема: integration
- Тема: vaccination
- Тема: service delivery
- Тема: systematic review
- Тема: maternal and child health
- Тема: infant
- Тема: HIV
- Тема: malaria
- Тема: family planning
- Тема: poliomyelitis
- Тема: epidemiology
- Тема: vaccine coverage
- Тема: surveillance
- Тема: polio eradication
- Тема: pertussis
- Тема: vaccines
- Тема: diagnosis
- Тема: vaccine security
- Тема: global OPV stockpile
- Тема: immunization policy
- Тема: inactivated poliovirus vaccine (IPV)
- Тема: oral poliovirus vaccine (OPV)
- Тема: vaccine production and distribution
- Тема: global health security
- Тема: poliovirus containment
- Тема: vaccine
- Тема: microplanning
- Тема: microplan
- Тема: LMIC
- Тема: routine childhood vaccines
- Тема: newcomer
- Тема: immunizations
- Тема: access
- Тема: equity
- Тема: qualitative methods
- Тема: Strategic Advisory Group of Experts (SAGE) on Immunization
- Тема: SAGE
- Тема: World Health Organization advisory group
- Тема: global immunization policy
- Тема: immunization strategy
- Тема: vaccination policy
- Тема: vaccination recommendations
- Тема: vaccine hesitancy
- Тема: cancer
- Тема: pediatric
- Тема: immunocompromised
- Тема: public health
- Тема: influenza
- Тема: COVID-19
- Тема: respiratory syncytial virus
- Тема: outbreaks
- Тема: maternal vaccination
- Тема: vaccination week in the Americas
- Тема: pandemic preparedness and response
- Тема: life-course immunization
- Тема: coverage increase
- Тема: zero-dose
- Тема: LMICs
- Тема: hepatitis E
- Тема: HEV 239
- Тема: shorter schedule
- Тема: immunogenicity
- Тема: efficacy
- Тема: zero dose
- Тема: under-five vaccination
- Тема: human centered design
- Тема: advocacy
- Тема: community-centric intervention
- Тема: National Immunization Technical Advisory Groups
- Тема: NITAGs
- Тема: WHO–UNICEF Joint Reporting Form
- Тема: measles
- Тема: under-immunized
- Тема: vaccine inequity
- Тема: herpes zoster
- Тема: varicella zoster virus
- Тема: health policy
- Тема: Central Africa
- Тема: big catch-up
- Тема: peer learning
- Тема: measles, mumps, and rubella
- Тема: MMR
- Тема: Denmark
- Тема: school
- Тема: healthcare
- Тема: education
- Тема: economic outcomes
- Тема: HPV vaccination
- Тема: girls
- Тема: supplementary immunization activities
- Тема: coverage
- Тема: disparities
- Тема: Togo
- Тема: immunization equity
- Тема: children with disabilities
- Тема: low- and middle-income countries
- Тема: vaccine barriers
- Тема: vaccination strategies
- Тема: inclusive healthcare
- Тема: adult
- Тема: health workers
- Тема: pregnant women
- Тема: elderly
- Тема: chronic diseases
- Тема: Shigella
- Тема: children
- Тема: phase III study
- Тема: endpoints
- Тема: safety
- Тема: dengue
- Тема: Qdenga
- Тема: CYD-TDV
- Тема: TAK-003
- Тема: Wolbachia
- Тема: antibody-dependent enhancement
- Тема: mRNA vaccines
- Тема: school-based programs
- Тема: n/a
- Тема: thema EDItEUR::M Medicine and Nursing